Utility of 30-Day Mortality Following Systemic Anti-Cancer Treatment as a Quality Indicator in Advanced Lung Cancer.

MLA

Roberts, Hayley Nicole, et al. “Utility of 30-Day Mortality Following Systemic Anti-Cancer Treatment as a Quality Indicator in Advanced Lung Cancer.” Clinical Lung Cancer, vol. 25, no. 5, July 2024, p. e211. EBSCOhost, https://doi.org/10.1016/j.cllc.2024.04.001.

APA

Roberts, H. N., Solomon, B., Harden, S., Lingaratnam, S., & Alexander, M. (2024). Utility of 30-Day Mortality Following Systemic Anti-Cancer Treatment as a Quality Indicator in Advanced Lung Cancer. Clinical Lung Cancer, 25(5), e211. https://doi.org/10.1016/j.cllc.2024.04.001

Chicago

Roberts, Hayley Nicole, Benjamin Solomon, Susan Harden, Senthil Lingaratnam, and Marliese Alexander. 2024. “Utility of 30-Day Mortality Following Systemic Anti-Cancer Treatment as a Quality Indicator in Advanced Lung Cancer.” Clinical Lung Cancer 25 (5): e211. doi:10.1016/j.cllc.2024.04.001.